menu Search
Novartis Healthcare
UNILAB, Inc

NOVARTIS PHARMA STEIN AG

Featured products of Novartis Pharma Stein
Bacrelba
Bacrelba FC tab 40 mg
asciminib
Packing/Price
60's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA06 - asciminib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
Lucentis
Lucentis soln for inj 10 mg/mL
ranibizumab
Packing/Price
(+ syringe) 2 mL x 1's (P24,426.00/box)
MIMS Class
Other Eye Preparations
ATC Classification
S01LA04 - ranibizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Vsiqq
Vsiqq soln for inj 120 mg/mL
brolucizumab
Packing/Price
(single use, type 1 colourless glass w/ grey rubber stopper and aluminum seal w/ violet flip-off cap + 1 filter needle in soft blister) 2 mL x 1's
MIMS Class
Other Eye Preparations
ATC Classification
S01LA06 - brolucizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Xenazole
Xenazole FC tab 2.5 mg
letrozole
Packing/Price
30's
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BG04 - letrozole : Belongs to the class of enzyme inhibitors. Used in treatment of neoplastic diseases.
Distributed by Novartis Healthcare
Bacrelba
Bacrelba FC tab 40 mg
asciminib
Packing/Price
60's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA06 - asciminib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
Lucentis
Lucentis soln for inj 10 mg/mL
ranibizumab
Packing/Price
(+ syringe) 2 mL x 1's (P24,426.00/box)
MIMS Class
Other Eye Preparations
ATC Classification
S01LA04 - ranibizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Vsiqq
Vsiqq soln for inj 120 mg/mL
brolucizumab
Packing/Price
(single use, type 1 colourless glass w/ grey rubber stopper and aluminum seal w/ violet flip-off cap + 1 filter needle in soft blister) 2 mL x 1's
MIMS Class
Other Eye Preparations
ATC Classification
S01LA06 - brolucizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Distributed by UNILAB, Inc
Xenazole
Xenazole FC tab 2.5 mg
letrozole
Packing/Price
30's
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BG04 - letrozole : Belongs to the class of enzyme inhibitors. Used in treatment of neoplastic diseases.

Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in